Minister of Health and Population Khaled Abdel Ghaffar stressed that the pharmaceutical sector remains a top state priority, underscoring the government’s commitment to safeguarding pharmaceutical security and ensuring the uninterrupted availability of medicines for all citizens.
The minister made the remark on Sunday during a meeting with Ali El Ghamrawy, Chairman of the Egyptian Drug Authority (EDA).
The meeting reviewed a host of key issues that directly affect the daily lives of millions of Egyptians, including the availability of medicines, the pharmaceutical tracking system, and efforts to localise pharmaceutical manufacturing.
Abdel Ghaffar reviewed the country’s secure strategic stockpile and sustainable alternatives for pharmaceutical and medical supply chains, with particular focus on emergency medications and treatments for chronic diseases.
The discussions aimed to ensure the continuity of supply and prevent any disruption in access to essential medicines for patients.
The meeting also highlighted the advanced pharmaceutical tracking system implemented by the Egyptian Drug Authority, which plays a critical role in protecting the market from counterfeit and smuggled medicines while ensuring the quality and safety of pharmaceutical products available to citizens.
The minister and the EDA chief reviewed progress made in localising the manufacturing of pharmaceutical products, in line with the state’s broader vision to enhance self-sufficiency.
These efforts represent steady steps toward building a strong national pharmaceutical industry capable of meeting the full needs of the Egyptian market, while also opening new opportunities for exports to global markets—thereby supporting the national economy and strengthening Egypt’s regional standing.
